| Exhibit
A |
Heroin, Cocaine, and Crack: Characteristics
and Effects |
| Exhibit
B |
Definitions of Substance Abuse and Substance
Dependence |
| Exhibit
C |
Basic Components of a Therapeutic Community
(TC) Program |
| Exhibit
D |
Drug Use Practices and Risk for HIV Transmission |
| Exhibit
E |
Important Terms Related to HIV/AIDS Surveillance |
| Exhibit
F |
CDC's AIDS Community Demonstration Projects |
| Exhibit
G |
Features of HIV Prevention Interventions |
| Exhibit
H |
Features of the NIDA Intervention Model |
| Exhibit
I |
Effective HIV Prevention Programs |
| Exhibit
J |
Collaborative HIV Prevention Efforts
in Correctional Systems |
| Exhibit
K |
Inter-Agency HIV Prevention Efforts |
| Exhibit
L |
A Suggested Taxonomy for Classifying
HIV Prevention Interventions |
| Table
1.1 |
Regional Patterns and Trends of Drug
Use |
| Table
1.2 |
Local Resources for Information on Drug
Use Trends and Patterns |
| Table
1.3 |
Metropolitan Areas Surveyed by CEWG |
| Table
2.1 |
High-Risk Practices and Behaviors Among
Drug Users |
| Table
2.2 |
Factors in Sharing Injection Equipment |
| Table
2.3 |
Indirect Sharing Practices |
| Table
2.4 |
Key Data Sources for Local HIV Prevention
Planning |
| Table
2.5 |
Primary Drug Injected by Persons With
HIV/AIDS Who Have Ever Injected Drugs, by State or City of Residence |
| Table
3.1 |
Eight Common Theoretical Factors |
| Table
3.2 |
Stages of Behavior Change |
| Table
3.3 |
Social-Level Approaches |
| Table
3.4 |
Guide to Evaluation Study Summaries |
| Table
4.1 |
Cities with Schools-Based Health Centers
Offering Condom Availability Programs |
| Table
4.2 |
Circumstances Permitting Disclosure of
Drug Treatment Patient Information |
This CDC Web site is no longer being reviewed or updated and thus is no longer kept current. This site remains to assist researchers or others needing historical content.